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Abstract
Malignant syphilis or lues maligna is a severe form of secondary syphilis that was commonly reported in the
pre-antibiotic era, and has now reemerged with the advent of the human immunodeficiency virus (HIV) epidemic.
However, the characteristic histopathological findings of malignant syphilis remain controversial. The aim of this case
report was to clarify the clinical and histopathological findings of HIV-positive malignant secondary syphilis. A Japanese
man in his forties complained of fever, skin lesions, headache, and myalgia without lymphadenopathy during the
previous 4 weeks. The skin lesions manifested as erythematous, nonhealing, ulcerated papules scattered on his trunk,
extremities, palm, and face. Although the skin lesions were suspected to be cutaneous T-cell lymphomas on
histological analyses, they lacked T-cell receptor Jγ rearrangement; moreover, immunohistochemical analyses
confirmed the presence of spirochetes. The patient was administered antibiotics and anti-retroviral therapy,
which dramatically improved the symptoms. On the basis of these observations of the skin lesions, we finally
diagnosed the patient with HIV-associated secondary syphilis that mimicked cutaneous T-cell lymphoma. The
patient’s systemic CD4+ lymphocyte count was very low, and the infiltrate was almost exclusively composed
of CD8+ atypical lymphocytes; therefore, the condition was easily misdiagnosed as cutaneous lymphoma. Although
the abundance of plasma cells is a good indicator of malignant syphilis on skin histological analyses, in some cases, the
plasma cell count may be very low. Therefore, a diagnosis of malignant secondary syphilis should be considered before
making a diagnosis of primary cutaneous peripheral T-cell lymphoma or lymphoma associated with HIV infection.
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Background
Lues maligna, also known as malignant secondary syph-
ilis or ulceronodular syphilis, is an aggressive and lethal
form of secondary syphilis. Although it was previously
eradicated in developed countries with the introduction
of antibiotics, it has reemerged recently [1–3]. The dis-
ease manifests as multiple skin lesions on the face and
extremities following a short incubation period; these
lesions are characterized by a nonhealing central ulcer
with peripheral extension and a thick, crusty covering.
The palms and soles are often affected, and fever,
myalgia, and headache commonly occur. Compatible
gross and microscopic morphology, a high antibody titer
on serologic tests for syphilis, Jarisch-Herxheimer reac-
tion following treatment, and dramatic response to anti-
biotic therapy are classical criteria used for diagnosing
malignant secondary syphilis [1, 3].
Since the 1900s, co-infection with malignant second-
ary syphilis and human immunodeficiency virus (HIV)
has been more frequently reported; with HIV infection
and lues maligna, the outcomes are even poorer than
previously reported with lues maligna alone in the pre-
HIV period [4]. There has been a recent increase in the
number of syphilis and HIV co-infection cases, and esti-
mates indicate that 16 % of all patients with syphilis and
28 % of male patients with syphilis in the United States
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are HIV positive [5]. In a Japanese clinical study con-
ducted from 1986 to 2000, 40.3 % of HIV-1-positive pa-
tients also tested positive for rapid plasma reagin (RPR)
[6]. The combination of syphilis and HIV is particularly
dangerous because eroded secondary syphilids increase
the risk of HIV infection, and HIV can alter the natural
history of syphilis [7]. A new syphilis infection increases
the viral load of HIV and decreases CD4+ cell counts in
HIV-infected patients [8]. Potentially because of B-cell
dysregulation, the RPR test tends to be masked by the
prozone phenomenon, especially in patients with HIV
[9]. Malignant secondary syphilis and central nervous
system syphilis are both lethal conditions. Therefore, it
has been suggested that all HIV-positive syphilis patients
should be treated with a penicillin-based regimen that is
adequate for the treatment for neurosyphilis [10].
Skin lesions mimicking lymphoma have been reported
in a simple infection of either syphilis or HIV. The
simple syphilis, particularly in secondary syphilis, in-
duces generalized lymphadenopathy, and lymphocyte-
dominant skin infiltration admixed with neutrophils,
histiocytes, and plasma cells, which can easily be inter-
preted as lymphoma cutis by pathologists [11]. The
abundance of neutrophils seen in these malignant syph-
ilis cases was also observed in the present case [11, 12].
In contrast, lymphoid proliferative lesions in a simple
HIV infection that are characterized by polyclonal
CD8+ lymphocytes that improve with only antiretro-
viral therapy (ART) have also been reported and
called lymphomas associated with HIV infection, dif-
fuse infiltrative lymphocytosis syndrome, and CD8+
pseudolymphoma [13].
In syphilis and HIV co-infection, skin lesions have been
reported as atypical cutaneous lymphoproliferative disor-
ders in patients with HIV [14]. Tosca et al. reported that
lymphocytes can be of both the CD4 and CD8 types,
[15] whereas Muche et al. reported that 85 % of the
skin-infiltrating lymphocytes in HIV patients were CD8+
T-cells [16]. However, the histopathological findings re-
main controversial. Recently, we encountered a case of
HIV-positive malignant secondary syphilis that histologi-
cally mimicked cutaneous peripheral T-cell lymphoma.
Here, we report the clinical and pathological manifest-
ation of the case and describe the correlation with the




A married Japanese man in his forties presented with
fever and 1- to 5-cm, well-demarcated, round-to-oval
erythematous pruritic skin macules on his trunk and
upper extremities (Fig. 1a). He complained of severe
headache and arthralgia and reported low-grade fever,
fatigue, and weight loss during the previous 4 weeks.
Superficial lymphadenopathy was unclear.
He had the following characteristics at admission:
height, 171 cm; weight, 49 kg; blood pressure, 98/
63 mmHg; pulse, 90 beats/min; and body temperature,
38.0 °C. His blood examination showed RPR positivity,
antibody 5.4 R.U, card method × 4, and Treponema palli-
dum (TP) antigen × 2713.6 U. Anticardiolipin and anti-
nuclear antibody tests were negative. The following
results were also obtained: white blood cells, 7470/μL
(neutrophils, 83.0 %; lymphocytes, 6.5 %; monocytes,
3.0 %; eosinophils, 3.5 %; basophils, 0.5 %; atypical
lymphocytes, 2.5 %; abnormal lymphocytes, 0.0 %; toxic
granule +; and hypersegmentation +); red blood cells,
354 × 104/μL; hemoglobin, 10.4 g/dL; hematocrit, 31.7 %;
mean corpuscular hemoglobin concentration, 32.8 %;
mean corpuscular hemoglobin, 29.4 pg; mean corpuscu-
lar volume, 89.5 fL; prothrombin time, 13.8 s, 78 %; pro-
thrombin time-international normalized ratio, 1.12;
activated partial thromboplastin time, 41.3 s; fibrinogen,
439 mg/dL; gamma-glutamyl transpeptidase, 80 U/L;
lactate dehydrogenase, 180 U/L; total cholesterol,
22 mg/dL; TP, 6.9 g/dL; immunoglobulin (Ig) G,
1879 mg/dL; IgA, 264 mg/dL; IgM, 186 mg/dL; blood
urea nitrogen, 8 mg/dL; creatinine, 0.63 mg/dL; C-reactive
protein, 5.99 mg/dL; and soluble IL-2 receptor (sIL2R),
1585 U/mL.
Based on skin biopsy, peripheral T-cell lymphoma not
otherwise specified (PTCL-NOS) was suspected (see
histological findings). For this pathological diagnosis,
sulfamethoxazole-trimethoprim, itraconazole, and pred-
nisolone were prescribed. At admission, syphilis and
HIV co-infection was detected on the basis of positivity
for the HIV antibody, HIV-RNA of 1.1 × 105 copies/mL,
and CD4+ T-cell count of 110/μL. Because he was con-
sidered a high-risk AIDS patient, ART consisting of
emtricitabine/tenofovir disoproxil fumarate plus efavir-
enz and methyl prednisolone was initiated. Electron
beam irradiation and narrowband ultraviolet B therapy
were also performed. Despite partial remission of the
skin lesions fever following the therapy, high fever re-
curred 1.5 months later, and the eruptions had generally
spread, producing large amounts of exudate. Persistent
fever due to indwelling catheter infection was suspected,
for which cefepime to amoxicillin treatment was initi-
ated. The fever reduced significantly, and the erup-
tions started to disappear. He was discharged from
the hospital without undergoing chemotherapy. Dur-
ing the 1-year follow-up at the clinic, he did not ex-
perience any symptoms.
Histological findings
On skin biopsy, diffuse infiltration of atypical lymphoid
cells was observed mainly in the upper to mid dermis
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(Fig. 1b). Some epidermotropism of the atypical lymph-
oid cells was present (Fig. 1c). The atypical lymphocytes
were denser around the skin appendages, and the dermal
vessels showed venulitis with extravasation of red blood
cells. There were abundant neutrophils, histiocytes, a
small number of plasma cells, and eosinophils (Fig. 1d).
Nuclear dust was not prominent. Atypical lymphoid cells
showed positive immunohistochemical staining for CD3,
1CD7, CD8 (Fig. 1e), granzyme B, and perforin. The
Ki-67 labeling index was high. Epstein-Barr virus-encoded
RNA was positive only in a few cells. Immunoreactivity
for CD4, CD20, CD30, and CD56 were negative.
Fig. 1 Clinicopathological findings. a. Skin lesions before treatment. These 1–5-cm erythematous lesions were scattered on the trunk. Lesions
larger than the size of a walnut were ulcerated and crusty. Palmer and planter lesions were also present. b. Nodular infiltration of the cells from
the epidermis to the upper subcutaneous. c. Epidermotropism of atypical lymphoid cells. d. In the dermis, there is severe inflammation around
the venules. Atypical lymphocytes, multinucleated leukocytes, and epithelioid histiocytes are present, but sparse plasma cells. e. Immunohistochemical
staining for CD8. Lymphocytes were exclusively immunoreactive for CD8. Atypical lymphocytes with nuclear twisting and indentation are also present
(arrows). f. In the bone marrow clot, a number of CD8+ lymphocytes are infiltrating, as indicated by immunohistochemistry. g. Atypical lymphocytes
and small lymphocytes are seen in the bone marrow smear, suggestive of non-neoplastic cells (arrowheads). h. Treponema pallidum is mainly
distributed in the dermis, especially in the perivascular space with histiocytes. Immunohistochemical staining for Treponema pallidum
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In the 4th edition of the WHO classification for tu-
mors, the differential diagnoses in skin lesions with
HIV-positive, CD8+ CD30-T-cell proliferation are as fol-
lows: primary cutaneous peripheral T-cell lymphoma
(primary cutaneous gamma delta T-cell lymphoma or
primary cutaneous CD8-positive aggressive epidermotro-
pic T-cell lymphoma), subcutaneous panniculitis-like T-
cell lymphoma, mycosis fungoides (rare CD8 subtype),
lymphomatoid papulosis (rare CD8 subtype), and lymph-
oma associated with HIV infection (rare manifestation).
The present lesion lacked T-cell receptor (TCR) re-
arrangement, massive epidermotropism, and panniculi-
tis. Therefore, we initially misdiagnosed the patient with
cutaneous PTCL-NOS with a cytotoxic phenotype.
For staging, CD8+ atypical lymphoid cell infiltration
(Fig. 1f ) and sparse CD4+ cells in the bone marrow clot
suggested involvement of CD8+ T-cell lymphoma. Al-
though very few abnormal lymphocytes were present in
the bone marrow smear (Fig. 1g), up to 10 % of all
nuclear cells were classified as atypical lymphocytes,
which we assumed to be a reactive change. Therefore,
re-evaluation of the skin lesions was performed. The
TCR rearrangement of both Jγ and CTβ was polyclonal.
The immunohistochemical staining for Treponema was
re-examined, using the same formalin-fixed paraffin block.
Infiltration of numerous spirochetes predominantly in
the dermis was observed (Fig. 1h). On the basis of
these data and the clinical course, we finally concluded
that the skin lesions were not neoplastic and were sec-
ondary syphilids that mimicked T-cell lymphoma in an
HIV-positive host.
Discussion
Ordinary secondary syphilis presents various skin mani-
festations. However, approximately 80 % of patients
show superficial lichenoid/psoriasiform inflammation with
a plasma cell-, lymphocyte-, and histiocyte-dominant pat-
tern. Treponema pallidum distribution is also epitheliotro-
pic [18]. In contrast, inflammatory cells are deeper and
more complicated in malignant secondary syphilis. Lues
maligna is the more common name for malignant sec-
ondary syphilis in dermatology and is characterized by
Table 1 Number of CD4+ cells, results of the rapid plasma reagin (RPR) test for Treponema pallidum, and human immunodeficiency
virus RNA
PSL prednisolone, EB electron beam, UV narrowband ultraviolet B, AMPC amoxicillin, CFPM cefepime, ART antiretroviral therapy, TDF/FTC+EFV emtricitabine/tenofovir
disoproxil fumarate plus efavirenz, ND not done, RPR rapid plasma reagin, HIV human immunodeficiency virus
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dermal plasma cells admixed with lymphocytes, histio-
cytes, and neutrophils—neutrophilic venulitis is de-
scribed as a pattern of lues maligna—but spirochetes are
infrequently found [19, 20]. An appropriate Treponema
immunohistochemical staining technique might be needed
for diagnosis.
In our case, ART was not effective but a combination of
ART and antibiotics such as penicillin-G improved the
symptoms, while RPR antibody 5.4 R.U tested negative.
Venereal Disease Research Laboratory/Rapid Plasma
Reagin (VDRL/RPR) titers have been reported to range
between 1:16 and 1:4096 in HIV-negative classical malig-
nant syphilis [3]. In any event, an HIV-positive patient’s
sample requires diluted re-examination for prozone
phenomenon. RPR was originally designed as a method
for detecting autoantibodies, and its titer reflects tissue in-
flammation level caused by Treponema pallidum infection.
Therefore, in HIV-positive cases, immunodeficiency may
lead to low titer-positive and prolonged negative conver-
sion. We also think that systemic CD4+ lymphocytopenia
caused by a severe HIV infection and some hypercytokine-
mia caused by lues maligna might play a significant role on
the appearance of numerous CD8+ atypical lymphocytes
and fewer plasma cells (Table 1).
Conclusions
When ulcerated skin lesions are observed in a patient with
syphilis and HIV co-infection, a diagnosis of lues maligna
should be considered before diagnosing the patient with
cutaneous lymphoma, even if there is an abundance of
CD8+ lymphocytes without plasma cells. Slight neutro-
philic venulitis might be an important finding. The diag-
nosis could be confirmed by the serological syphilis test
(STS) or Treponema pallidum hemagglutination (TPHA)
test (both positive), immunohistochemical positivity for
Treponema pallidum, and TCR polyclonality in the skin
lesion. Cases of co-infections with malignant syphilis and
HIV have been on the rise, and delayed diagnosis is dan-
gerous not only for the patient but also for public health.
The present case demonstrates that pathologists should
be aware of the possibility of lues maligna with HIV, mim-
icking cutaneous T-cell lymphoma.
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